
Sam Koppelman
@sammykoppelman
Publisher, @hntrbrkmedia. Co-founder @HealthMayday. NYT best-selling author. Sufferer @NYKnicks. See disclosures below.
ID: 325886383
http://hntrbrk.com 29-06-2011 01:21:33
3,3K Tweet
10,10K Followers
1,1K Following

Hunterbrook first reported on the kafkaesque Liquidia / United Therapeutics saga a few months ago. Today, after years of delays, the FDA finally approved Liquidia’s drug for pulmonary hypertension. Laura Wadsten wrote a deep dive on what this means for patients:

Hahahaha OSINTtechnical just helped the world avert a Franz Ferdinand moment in Hormuz — People, stop sharing unverified stuff.


So I guess this was, ah, kind of a scoop? HUGE shoutout to OSINTtechnical & Sam Koppelman who beat every other publication to this critical story by several hours Hunterbrook — & thanks to NYT for highlighting our work.


BREAKING: As the Trump admin reportedly prepares to pull funding for war crime investigations — and missile defense systems for Ukraine — a new exposé reveals that microelectronics from American tech giants like Intel and Texas Instruments continue to enable precision strikes on

New: Components from over 100 Western companies, including Intel and Texas Instruments, are enabling the Russian Air Force’s bombing campaign on Ukraine, including strikes on civilians. An investigation from NAKO and IPHR with support from Hunterbrook:


BREAKING: Teradyne Tapped For Amazon’s Revolutionary New Robot Amazon’s Vulcan robot has been hailed as a “step change” breakthrough—the first warehouse robot with a “sense of touch.” But here’s what’s been missed: The arms come from Teradyne. A Hunterbrook Media x Citrini